Neurorx Inc., of Radnor, Pa., has entered an agreement with special purpose acquisition company Big Rock Partners Acquisition Corp, in which the firms will merge, with shares trading on Nasdaq under the ticker NRXP. Under the terms, Big Rock will issue to Neurorx’s current equity holders an aggregate of 50 million shares of Big Rock […]

Big Rock Partners Acquisition Corp., a special purpose acquisition company, has entered into a merger agreement valued at $500 million with NeuroRx. NeuroRx, which is based in Wilmington and has its operational headquarters in Radnor, is a clinical-stage pharmaceutical company developing treatments for Covid-19 and bipolar depression. The company also has operations in Israel. Under […]

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel, “off the shelf” cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell therapy platform and in-house development and manufacturing capabilities. Their lead program features the manufacture and transplant of retinal pigment epithelium cells for the treatment of dry age-related macular degeneration, […]